Patient care

Terry Gernsheimer, M.D.

Professional Bio

Dr. Terry Gernsheimer is Director of Medical Education at the Bloodworks Northwest, a practicing hematologist and has over 20 years experience of consultation in hemostasis, surgical bleeding and thrombocytopenia.

Patient Care Bio

  • Attending, Hematology and Leukemia University of Washington Medical Center and Seattle Cancer Care Alliance
  • Special interests: Immune Thrombocytopenia; Hemostasis in cardiovascular surgery; Obstetrical hemostasis; Transfusion therapy in patients with hematologic malignancy; Transfusion in stem cell transplantation

Awards & Honors

  • Phi Beta Kappa
  • 2012 – Inaugural University of Washington Chief of Medicine Service Award for Inpatient Medicine
  • 2010 Hematology/Oncology Best Teacher Award
  • 2007 American Society of Hematology Plenary Presentation

Current Appointments

  • Professor of Medicine, Department of Internal Medicine, Division of Hematology, University of Washington, Seattle, WA
  • Medical Director of Transfusion – Seattle Cancer Care Alliance
  • Director of Medical Transfusion Services, University of Washington Medical Center
  • Active Medical Staff Privileges, University of Washington Medical Center, Harborview Medical Center, Seattle Cancer Care Alliance, Swedish Medical Center; Seattle, WA

Board Certified Specialties

  • Hematology

Research Interests

  • Immune Thrombocytopenia – therapy and pathophysiology
  • Transfusion in the Hematopoietic Stem Cell Transplant patient
  • Platelet transfusion in hematologic malignancy

Education

  • MD | Medicine | University of New York at Stony Brook
  • BS | Biology | University of New York at Buffalo

Post-Doctoral Training & Residency

  • Internal Medicine Residency, New England Deaconess Hospital; Boston, MA
  • Hematology Fellowship, University of Washington; Seattle, WA

Selected Publications

  1. Gernsheimer TB, Stratton J, Ballem PJ, Slichter SJ:  Mechanisms of treatment responses in autoimmune thrombocytopenic purpura (AITP).  N Engl J Med 320:974-980, 1989.
  2. Trial to Reduce Alloimmunization to Platelets (TRAP) Trial Study Group [including Gernsheimer T.  A randomized trial evaluating leukocyte-reduction and UV-B irradiation of platelets to prevent alloimmunization and refractoriness to platelet transfusions.  N Eng J Med 337:1861-1869, 1997.
  3. Collier AC, Kalish LA, Busch MP, Gernsheimer T:   Leukocyte-reduced red blood cell transfusions in patients with anemia and human immunodeficiency virus infection: the viral activation transfusion study: a randomized controlled trial.   JAMA 285:1592-1601, 2001.
  4. Enright H, Davis K, Gernsheimer T, McCullough JJ, Woodson R, Slichter SJ. Factors influencing moderate to severe reactions to PLT transfusions: experience of the TRAP multicenter clinical trial. Transfusion. 2003 Nov;43(11):1545-52. PubMed PMID: 14617313.
  5. Slichter SJ, Kaufman R, Assman S, Brecher ME,  Gernsheimer T, et al.  Effects of Prophylactic Platelet (Platelet) Dose on Transfusion (Transfusion) Outcomes. (PLADO Trial) Blood (ASH Annual Meeting Abstracts) 112: 285, Nov. 2008
  6. Kuter DJ, Gernsheimer TB. Thrombopoietin and platelet production in chronic immune thrombocytopenia. Hematol Oncol Clin North Am. 2009 Dec;23(6):1193-211. Review. PubMed PMID: 19932428; PubMed Central PMCID: PMC2789970.
  7. Gernsheimer TB. Platelet transfusion in the 21st century: where we’ve been and where we’re going. ISBT Science Series.  Special Issue: State of the Art Presentations. 21st Regional Congress of the ISBT, Europe – Lisbon, Portugal, June 18–22, 2011 Volume 6, Issue 1, pages 245–248, July 2011
  8. Gernsheimer, TB. Thrombocytopenia in pregnancy: is this immune thrombocytopenia or … ?, Hematology Am Soc Hematol Educ Program. 2012;2012:198-202. doi: 10.1182/asheducation-2012.1.198.

Bloodworks Northwest
921 Terry Avenue
Seattle, WA 98104
Phone: (206) 292-6521

Your gift of blood, time or money saves lives.